Latest Headlines
-
Summit Health Announces Internalization Of Genomic Testing Cooperative State-Of-The-Art Next Generation Sequencing DNA And RNA Profiling Tests For Tissue And Liquid Biopsy Of Solid Tumors And Hematologic Neoplasms
5/20/2025
Summit Health, part of Village MD and Genomic Testing Cooperative (GTC), the global leader in RNA innovation, are excited to announce today the launch of a newly established next generation sequencing service at the Summit Health laboratory in Woodland Park, NJ to offer comprehensive DNA and RNA profiling of solid tumors and hematologic neoplasms.
-
Bruker Introduces The S8 TIGER Series 3 High-Performance WDXRF Spectrometer For Elemental Analysis In Industry And Research
5/20/2025
Bruker, a global leader in analytical instrumentation, launches the S8 TIGER Series 3 high-power Wavelength Dispersive X-Ray Fluorescence (WDXRF) spectrometer.
-
Frame And Labcorp Collaborate To Expand Access To Fertility Care And Testing Services
5/20/2025
Frame, the collaborative care platform transforming access to reproductive and fertility care, today announced a strategic collaboration with Labcorp, a global leader of innovative and comprehensive laboratory services, to enable patients to seamlessly access Labcorp's comprehensive suite of fertility testing services, including hormone and genetic testing.
-
Bionano Laboratories Announces A Second Category I CPT Code For OGM Established By The AMA; This One For Use In Whole Genome Analysis For Constitutional Genetic Disorders
5/19/2025
Bionano Laboratories, a wholly-owned subsidiary of Bionano Genomics, Inc. (Nasdaq: BNGO) that offers CLIA-certified laboratory developed tests (LDTs) based on optical genome mapping (OGM), today announced that the editorial panel of the American Medical Association (AMA) established a new Category I Current Procedural Terminology (CPT®) code for the use of OGM in cytogenomic genome-wide analysis to detect structural and copy number variations related to constitutional genetic disorders.
-
Revvity's EUROIMMUN Unveils New Fully Automated Instrument For Specialty Testing
5/19/2025
Revvity, Inc today announced the launch of its new IDS i20 analytical random access platform from EUROIMMUN, enabling full automation of chemiluminescence immunoassays (ChLIA).
-
Gene Solutions And NEWCL Forge Strategic Partnership To Advance Genetic Testing In Taiwan
5/16/2025
In a groundbreaking move, Gene Solutions, a leader in prenatal and oncology genetic testing, and NEWCL Biomedical Laboratory, Taiwan's pioneering clinical laboratory with LDTs certification, have joined forces to establish an advanced Next-Generation Sequencing (NGS) laboratory in Taiwan.
-
Safe, Portable, And Trackable Instrument For Transporting Biological Samples
5/14/2025
The liquid nitrogen vapor-based CryoPod Carrier from Azenta Life Sciences provides a safe, portable, and trackable solution for hand carrying temperature-sensitive materials between labs, providing protection below -150°C for over 3 hours.
-
Team Develops Digital Lab For Data- And Robot-Driven Materials Science
5/14/2025
Researchers at the University of Tokyo and their collaborators have developed a digital laboratory system that fully automates the material synthesis and the structural and physical property evaluation of thin-film samples.
-
Prevencio Receives FDA Breakthrough Device Designation For HART CADhs, Its Artificial Intelligence-Driven Blood Test For Obstructive Coronary Artery Disease
5/13/2025
Prevencio, Inc., the leader in artificial intelligence-powered blood tests for cardiovascular diagnostics, announces that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation to its HART CADhs test.
-
Evexia Diagnostics And Mosaic Diagnostics Partner To Expand Access To Innovative Specialty Testing
5/13/2025
Evexia Diagnostics, a leading provider of comprehensive clinical laboratory services, is excited to announce a strategic partnership with Mosaic Diagnostics, the global pioneer of specialty diagnostic testing.